New Hire Brings Pharmaceutical Federal Contracting and Compliance Expertise

March 10, 2009 - PRLog -- PHILADELPHIA, PENNSLYVANIA  – Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm is pleased to announce that David Rice has joined the management team as Director of Federal Contracting.

David Rice has over 25 years diverse pharmaceutical industry experience including FSS Contracting, Business Development, FSS Compliance, Pricing and Contracting, Finance and Auditing.  Prior to his work at Workforce Strategies, Inc. (WSI), Dave held key positions in Auditing, Pricing and Contracting and Federal Government Compliance at Pharmacia, Pharmacia & Upjohn and The Upjohn Company.  

“Dave’s work with pharmaceutical manufacturers and his vast experience and knowledge in the federal government market will be a valuable asset to CIS and compliments our staffing across Government Programs participation,” said Chris Cobourn, VP Regulatory Compliance and Practice Lead.  

“This is especially true now with many companies needing assistance with their 5-year Federal Supply Schedule solicitations, and with the government looking at additional ways to procure pharmaceutical products, such as blanket agreements and Corporate Exigency Contract’s. His experience, operations and business development abilities add immediate value and will enhance our client service capabilities.”

David Rice formerly held the position of Chairman of AMSUS-Sustaining Members (Association of Military Surgeons of the United States) an industry organization that brings together private healthcare industry representatives with key Department of Defense, Department of Veterans Affairs, and U.S. Public Health Service decision makers.

# # #

About CIS:

CIS is a pharmaceutical compliance consulting firm specializing in establishing a “Culture of Compliance” by providing a deep understanding of industry regulations, innovative and practical approaches and fit-for-purpose solutions.

CIS consultants understand and specialize in adherence to statutes, regulations and requirements of health care programs that have the greatest impact on research, development and commercial activities. This allows clients to proactively manage risk through identification and integration of appropriate compliance strategies.

For more information: www.cis-partners.com